A team from Takeda Pharmaceutical has developed a new model for monitoring bioreactors that could speed up process development. The scientists used Lonza’s Modular Automated Sampling Technology (MAST) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results